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Background: Bovine viral diarrhea virus (BVDV) is one of the most important pathogens in cattle. Previously, BVDV
sub-genotypes of 1b, 1c, 1d, and 1 m were detected in China. However, isolation of BVDV type 1a from cattle has
not been reported in China. In 2010, twenty nasal swabs and blood samples were collected from the cattle
suspected BVDV infection in Henan province, China. A BVDV isolate was isolated using cell culture, and the
pathogenesis of the virus isolate was studied.
Methods: Virus isolation was performed on MDBK cells. The virus identification was conducted by RT-PCR,
neutralization test and immunofluorescence assay. In order to determine the genotype of the newly isolated virus,
the 5′ un-translated region (5′UTR) of the virus isolate was cloned, sequenced and phylogenetically analyzed. To
evaluate the virulence of the virus isolate, four BVDV sero-negative calves were intranasally inoculated with the virus
suspension. Rectal temperatures and clinical signs were recorded daily. Blood samples were analyzed for changes in
white blood cell counts, and tissue samples were taken for histopathology analysis.
Results: A new isolate of bovine viral diarrhea virus (BVDV), named HN01, was isolated from the nasal swabs using
MDBK cell culture. The HN01 strain caused cytopathic effect (CPE) in MDBK cell cultures after two passages. The
virus specifically reacted to BVDV1-specific monoclonal antibody in an immunofluorescence assay. A fragment of
288 bp of genome from this isolate was amplified by the RT-PCR. Phylogenetic analysis of 5′UTR indicated that the
virus was BVDV 1a. In the pathogenesis study, four calves experimentally infected with the BVDV strain developed
depression, cough and other clinical signs. Calves showed high temperature over 40°C, and white blood cell counts
dropped more than 40%.
Conclusions: A new subgenotype 1a strain of BVDV was firstly isolated from dairy cattle in China. The experimental
infection showed that the virus was moderate pathogenic to cattle and can be used as a BVDV challenge virus to
evaluate the efficacy of BVDV vaccines in the target animals.
Keywords: Bovine viral diarrhea virus, BVDV, Cattle, Phylogenetic analysis, Pathogenesis, ChinaBackground
Bovine viral diarrhea virus (BVDV) is a great economi-
cally pathogen in cattle and other ruminants in the
world [1-10]. The virus is associated with several clinical
symptoms, including diarrhea, respiratory disease, con-
genital malformations, reproductive disorders and mu-
cosal disease [9,11-14].* Correspondence: wuhua@sinovetah.com
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stated.BVDV belongs to the genus pestivirus with classical
swine fever virus and border disease virus in the family
Flaviviridae. The genome of the BVDV consists of a
single positive-stranded RNA, which usually have a
length of 12.3 kb [15]. Two biotypes of BVDV catego-
rized as cytopathogenic or noncytopathogenic based on
their activity in cell culture have been recognized in the
past years [16,17]. Based on the basis of the nucleotide
sequence of 5′-untranslated region (5′UTR), Npro or E2
gene, BVDV strains can be divided into two different ge-
notypes, BVDV1 and BVDV2 [18]. Each genotype can betd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 Immunofluorescence test result on MDBK cells.
(A) BVDV was detected by indirect immunofluorescence assay.
Specific fluorescene in form of granules distribution all over the
cytoplasm was observed in the infected MDBK cells. (B) The
control cells.
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least 11 genetic subgroups of BVDV1 and three genetic
subgroups of BVDV2 are identified [3,6,18-24]. Recently, a
new virus referred to as HoBi-like BVDV3 was identified
in Europe, the virus can be divided into two sub-groups,
Thai origin and Brazilian origin [25]. BVDV1 spreads
worldwide in cattle population [22,23,26,27]. In the case
of BVDV2 species, the highest occurrence is reported in
the USA and Canada [25,28], partially in Japan [29-31],
Indian [3], South America [19], and occasionally in some
European countries [6,15,32-35].
Virulence is both important to understanding the
mechanisms of pathology and selecting the challenge
strains for evaluation of a vaccine. Variation in virulence
among BVDV2 strains has been extensively repor-
ted [36-38], but much less information is available on
variation in virulence among BVDV1 strains. To date,
the strain NY-1 has been used as a challenge strain for
evaluating efficacy of vaccine protection against BVDV1.
While it is well characterized, the clinical presentation
infected with NY-1 indicates it is more likely a low
virulence strain [39]. So investigating an efficacious
challenge virus to access the vaccine efficacy is very
important.
To the present, many subgenotypes of BVDV1 have
been isolated and detected in China [27,40,41]. Based on
the phylogenetic tree, the clustering of BVDV1b and
BVDV 1 m were the major prevalent subgenotypes in
China [27,41,42]. However, BVDV subgenotype 1a was
not isolated from cattle in China. Moreover, pathogen-
esis of above all strains was seldom reported.
In this study, one virus was isolated from nasal swabs of
cattle using MDBK cell cultures, and identified as a BVDV
isolate by the virus neutralization test, reverse transcrip-
tase-polymerase chain reaction (RT-PCR) method and
immunofluorescence assay. To investigate the genetic sub-
group of the strain, the 5′UTR gene of the virus was se-
quenced and compared with other 13 reference BVDV
strains by phylogenetic analysis. The pathogenesis of the
virus was evaluated by intranasally inoculating to four sus-
ceptible calves to assess the potential endemic risk to the
cattle herd in China.
Results
Virus isolation
A virus isolate was isolated from the nasal swab samples
after two blind passages on MDBK cells. The MDBK
cells inoculated with nasal swab samples developed
obvious cytopathic effects (CPE) as cells appeared ag-
gregated and formed net-like in the monolayers within
48 hours of incubation. The non-inoculated control cells
did not show the CPE. Specific fluorescent staining
showed the appearance in form of granules distribution
all over the cytoplasm in the infected MDBK cells, whenan indirect immunofluorescence test was conducted using
BVDV1 type-specific monoclonal antibodies (E2/gp53
IgG2a Isotype, VMRD, USA). The control cells did not
show any fluorescence (Figure 1).
In virus neutralization assay using BVDV anti-sera, re-
sults revealed that the inoculated MDBK cells did not
show CPE after mix of the virus fluids with BVDV1
positive serum, but cells inoculated with virus fluid only
developed CPE. These results indicate that the virus iso-
late was a BVDV 1 strain.
Amplification, sequencing, and analysis of 5′UTR
The fragment of 288 bp of 5′UTR gene was amplified
from the isolated virus by RT-PCR. The amplified pro-
duct was purified, cloned and sequenced. The sequence
of the isolated BVDV1 strain was compared to the refe-
rence sequences using BLAST program. Result revealed
that the isolated BVDV 1 strain was similar with the
BVDV strains Singer, with sequence identity about 95%.
The sequence of 5′UTR has been deposited in GenBank
with the accession No.JX878887.
Phylogenetic analysis
Phylogenetic analysis based on 5′UTR revealed the strain
HN01 was closed to BVDV1a Singer (L32875). The homo-
logy for nucleotide of 5′UTR is 95.3%, and with the strain
SH1060 (JN248741) was 89.2%. This result indicates that
the newly isolated BVDV strain, HN01, belongs to sub-
group BVDV 1a of genotype BVDV1 (Figure 2).
Experimental infection
Clinical signs were scored based on clinical severity,
included depression, loss of appetite, nasal discharge, dis-
tress, excessive salivation, and elevated rectal tempera-
tures. Two of the four BVDV infected calves developed
significant clinical signs with nasal discharge and depres-
sion beginning at 2 days post-challenge (dpi), and sub-
sequently 3 of four infected calves showed asthma and
Figure 2 Phylogenetic tree analysis based the 5′UTR. The tree was created using the nucleotide sequences of the 13 BVDV strains retrieved
from GenBank. The phylogenetic tree was prepared using the Neighbor-Joining method.
Figure 3 Experimental infection intranasal inoculating with the
HN01 stain. (A) Elevated rectal temperatures. (B) Decrease of white
blood cell counts.
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clinical signs during the experiment course. The rectal
temperature of cattle #655 was over 40°C from 6 dpi to 8
dpi with the highest temperature of 41.4°C. The rectal
temperature of cattle #642 was over 40°C at 2, 5 and 6 dpi
with the highest recorded temperature of 40.1°C. The
rectal temperature of animal #675 was over 40°C from
5 to 7 dpi with the highest temperature of 41.1°C. The
rectal temperature of cattle #666 was elevated to 40°C
from 2 to 4 dpi with the higest temperature of 40.3°C
(Figure 3A).
WBC counts of challenged calves started decreasing
from day 2 post-challenge. The WBC counts of 655#
dropped significantly from 8.6 (1000 per mm3) at day 0
to 3.6 (1000 per mm3) at 4 dpi, a 58% reduction to the
initial number. 642# decreased from 7.2 (1000 per mm3)
(0 day) to 3.0 (1000 per mm3) (6 dpi), a 58% reduction
to the initial number. The cattle of 675# decreased from
10.3 (1000 per mm3) (0 day) to 4.8 (1000 per mm3)
(2 dpi), a 53% reduction to the initial number. The cattle
of 666# decreased from 10.1 (1000 per mm3) (0 day) to
4.6 (1000 per mm3) (6 dpi), a 54.5% reduction to the
initial number. Average greatest decline of WBC counts
among the control animal group was less than 20%,
which were significantly less (P < 0.05) than those of the
challenge group (Figure 3B).
Viral detection was positive from 2 dpi to 8dpi in nasal
samples. Viral shedding was detected by virus isolating in
MDBK cells from nasal swabs. Two infected cattle had
viral shedding as early as 2 dpi. The long shedding period
reached to 8 days after inoculation, and the highest she-
dding peak was reached at 4-8 dpi.
Two randomly chosen calves (#675 and #642) and
one mock calf (#799) were euthanized at 8 dpi for histo-
pathology analysis. Gross pathological findings includedhemorrhages in the spleen and mesenteric lymph nodes.
Histopathologic changes included thymic and spleen atro-
phy, the lymph node was lymphadenopathy and hemorrhage,
and lymphoid depletion of the Peyer′s patches in all
the infected calves (Figure 4). All of the samples from
the control cattle did not show pathological changes.
Wang et al. Virology Journal 2014, 11:8 Page 4 of 8
http://www.virologyj.com/content/11/1/8Discussion
This study was the first report on BVDV 1a isolated from
cattle in China, and the pathogenesis of the isolate was
tested by experimental infection. Similar virus at the gen-
etic subtype was detected in pigs in China [43]. Identifica-
tion of BVDV 1a in cattle and swine seemed that the virus
have evolved well to replicate in different species. To our
knowledge, the diversity of the genotype is a dominant
character of the BVDV. Phylogenetic analysis is useful for
molecular epidemiological studies and vaccine research.as
well as tracing the origin of newly introduced viruses
[19,44-46]. The 5′UTR analysis is commonly used to
classify the genotypes of BVDV strains. To investigate the
molecular feature of the strain, 13 reference sequences
(Table 1) in China, USA and Korea field isolates were used
to phylogenetic analysis. A high genetically identity with
the BVDV1a strain was detected among all the reference
sequences. Recently, a BVDV 1a strain named SH1060 was
isolate from pigs in Shanghai, China [43], but the virus onlyFigure 4 Histopathologic changes of spleen, trachea and mesenteric
macrophages increased significantly. (B) The control was normal. (C) Some
infiltrated in the lamina propria; lymphocytes proliferated; lymphocytic folli
reticular cells proliferated and increased. (F) The control was normal.has the 89.2% homology of 5′UTR with the HN01 reported
in this study. This may suggest that the virus have the great
variation in evolution between the different kind species.
The subgroup of BVDV might be correlated with the
geographical origin [47]. Previous study indicated that the
BVDV 1a subtype was predominant and widespread in
neighboring countries, such as Korea and Japan [47,48]. In
China and India, BVDV 1b was the predominant subgeno-
types [27,49]. Hence, the isolated BVDV1a strain in this
study may be originated from the import of infected live-
stock. The findings of the current study also suggest a
possible role of BVDV in the etiology of diarrhea and
bovine respiratory disease. In addition, the presence of
BVDV could represent a clinical threat to diary and cattle
industry in China.
In this study, calves infected strain HN01 of BVDV1a
showed the mild clinical signs, high rectal temperature
and lymphopenia, which suggested that the strain had
the moderate virulence to cattle. Previous studies on thelymph nodes. (A) Red pulp of the spleen hemorrhage, hemosiderin
mucosal epithelium of trachea swollen; neutrophil and plasma cells
cular increased. (D) The control was normal. (E) Macrophages and
Table 1 Reference sequences from GenBank
S. No Isolate name Accession number in GenBank Country
1 Singer L32875 USA
2 Osloss M96687 USA
3 New_York93 AF502399 USA
4 HN01 JX878887 China
5 ZM-95 AF526381 China
6 JX0929 JN248736 China
7 SD0803 JN248727 China
8 HEN1003 JN248731 China
9 Zeku26 KC414604 China
10 JZ05-1 GQ888686 China
11 SH1060 JN248741 China
12 KB02 GQ495700 Korea
13 08GB45-2 JQ418631 Korea
14 4-81 GQ985460 Korea
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the low virulent strains were characterized with a sub-
clinical course, a mild short-term pyrexia, rectal tempe-
ratures between 39.2°C and 40.0°C for 1-2 days, and a
drop in circulating lymphocytes ranging between 20%
and 40% [50]. In contrast, clinical signs infected with a
high virulent strain were severe with a longer term and
more severe pyrexia, temperatures above 40°C, ranging
upwards to 41.7°C for 3 or more days, decreases of
greater than 40% in circulating lymphocytes and de-
creases of greater than 40% in platelets. Death losses
ranging between 20% and 50% have been observed in
field outbreaks associated with highly virulent BVDV2
strains [36,39,51]. Although the experimental animals
showed over 40°C for 2 days, over 40% WBC drop, the
virus was categorized as moderate virulence due to the
lack of severe clinical signs. This study demonstrated
that strain HN01 was an alternate challenge strain in
addition to the currently available strain NY-1 for vac-
cine efficacy test from the USDA [39]. Furthermore,
much of the research on BVDV virulence demonstrated
that the clinical signs, such as depression, febrile re-
sponse and excessive lacrimation were more reprodu-
cible than hemorrhage or diarrhea. It may be suggested
that low virulence strains were more dominant in nature
[52-54]. Despite the lack of severe clinical signs, infec-
tion with BVDV may transiently compromise the im-
mune system and thus possibly predisposes cattle to
secondary infections [52]. Measures such as vaccination
should be taken to control BVDV1 infection.
Conclusions
In this study, a BVDV strain genotype 1a was firstly iso-
lated from cattle herd in China. The study carried out amolecular epidemiology and pathogenesis on the strain.
Calves inoculated with the isolate developed clinical signs,
including high temperature, depression, cough and nasal
discharge. The results confirmed the existence of the
BVDV type 1a in China, and it may be helpful in preven-
ting the BVD in China and a challenge virus strain for effi-
cacy evaluations of vaccines.
Materials and methods
Samples and virus isolation
Twenty nasal swabs and blood samples were collected
from the cattle that showed mild respiratory clinical
signs, such as nasal discharge and cough in Henan pro-
vince, China in 2010. The nasal swab samples were
collected and put into a tube containing 2 ml DMEM
(HyClone, USA) supplemented with 10% horse serum
(Hyclone, USA), 150 μg/ml gentamicin sulfate (Sigma,
USA), 7.5 μg/ml fungizone (Sigma, USA), and Strepto-
mycin at 100 μg/ml. Three milliliter (3 ml) blood sam-
ples were collected using an EDTA vacuum blood tube
from the jugular vein. All the samples were kept at
2-8°C and quickly transferred to the laboratory. Nasal
swabs were inoculated into MDBK cell monolayers in
24-well tissue culture plates for virus isolation. Briefly,
following centrifugation at 1500 rpm for 10 min, the
samples were filtered through 0.45 μm membrane
(Sigma, USA) and then inoculated onto the MDBK cell
monolayer cultured in 0.5 ml DMEM (HyClone, USA)
supplemented with 6% horse serum (Hyclone, USA) in
24-well cell culture plates, and incubated at 37°C, with
5% CO2 for 2 hours. Then, the supernatants were dis-
carded, and plates were rinsed twice with PBS (pH7.2,
0.01 mol/L), and 1 ml DMEM (HyClone, USA), with
3.5% horse serum was added. The infected-MDBK cell
plates were checked daily and appearance of cytopathic
effects (CPE) was observed and recorded. If the CPE was
not found, the cultures were frozen and thawed twice
and the clarified supernatant was passaged three times
in MDBK cells. Un-infected MDBK cultures were in-
cluded as negative controls and MDBK cells inoculated
with BVDV NM01 strain, which was previously isolated
and identified by our laboratory, was used as positive
control. After 3-4 days of incubation at 37°C, with 5%
CO2 supply, the virus was confirmed by immunofluo-
rescence on cell monolayers as described below.
Virus neutralization test
To identify the isolated virus, virus neutralization (VN)
test was conducted using antisera raised in cattle against
BVDV1a NM01, a vaccine strain in our laboratory. Briefly,
virus fluids were mixed with the equal volume hyper-
immune antisera (antibody VN titer ≥ 1∶64) and incu-
bated at 37°C for one hour, and then the mixture was
transferred into MDBK cell cultures in the 96-well tissue
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5% CO2 supply, the plates were observed for CPE to
determine if the virus isolate was neutralized by the BVDV
antisera. The antisera positive control and negative con-
trol were also included in this test.
Immunofluorescence assay
To detect the BVDV in the infected-MDBK culture, an
immunofluorescent assay (IFA) was conducted as fol-
lows. Briefly, cell lysate was added to each of four wells
of a 96-well MDBK tissue culture plate. Positive virus
(NM01 strain) and DMEM media (negative control)
were also added to 4 wells respectively in the test. Then
plates were incubated for 4 days at 37°C, with 5% CO2
supply. Then, the supernatants were dumped and plates
were fixed with the mixture of 80% acetone and 20%
methyl alcohol; the fixed plates were incubated with
monoclonal antibody specific to anti-BVDV1 (E2/gp53
IgG2a Isotype, VMRD, USA). Finally, the rabbit anti-
mouse fluorescein isothiocyanate (FITC)-conjugated
immunoglobulin G (IgG) (Sigma, USA) was added to
the plates, then incubated in a 37°C humid box for an
hour. The plates were examined for fluorescence under
a fluorescent microscope (Zeiss Axioskop-40, Germany).
PCR amplification and sequencing
Primers (Forward: 5′ATGCCCTTAGTAGGACTAGCA3′;
Reverse: 5′TCAACTCCATGTGCCATGTAC3′) for 5′
UTR gene sequence of BVDV were designed according to
the BVDV strain Singer (GenBank accession number
L32875) and strain NADL (GenBank accession number
M31182). Total BVDV RNA was extracted from infected
MDBK cell fluids using Trizol reagent (Invitrogen, China)
according to the manufacturer′s instructions. The reverse
transcription polymerase chain reaction (RT-PCR) was
carried out using 5 μl of RNA extraction samples and 1 μl
of BVDV reverse primer as reverse transcription primer in
a 0.2 ml tube for 5 min at 70°C; and the tube was added
with 1 μl (200U) M-MLV reverse transcriptase RNase
inhibitor and 2 μl RNAse-free water, and then was incu-
bated for one hour at 42°C. The amplification of cDNA by
PCR was carried out in a total volume of 50 μl solution
containing 1 μl cDNA, 5 μl 10 × Buffer, 3 μl 2.5 mmol/L
dNTP, 0.5 μl each primer, 0.5 μl Platinum Pfx DNA poly-
merase and 39.5 μl sterile water. Amplification was per-
formed as follows: 95°C for 5 min, and then submitted to
30 cycles of amplification. The conditions for the amplifi-
cation were 1 min at 94°C, 1 min at 55°C, and 1 min at
72°C, then with a final extension at 72°C for 10 min. The
PCR products were detected by electrophoresis through a
1% agarose gel stained with ethydium bromide and visua-
lized under UV light. The target fragment of PCR pro-
ducts were purified and cloned into pMD18-T vector
(TaKaRa, Japan), and then transfected into E.coli DH5αcells. The positive clones were selected for sequencing by
Shanghai Invitrogen Biotechnology Co., Ltd.
Sequences analysis
The sequence analysis was performed by computer soft-
ware DNASTAR (Madison, Wis USA) and MEGA5.1. The
5′UTR gene sequence of the virus isolate was evaluated
for further sub-genotype classification and compared to
13 BVDV reference sequences (Table 1) from NCBI
database information to develop a phylogenetic tree.
Percent identities and divergences were calculated using
Neighbor-Joining method of Mega5.1 software.
Experimentally infection
Calves and housing
Six 4-month old calves were obtained from a calf farm in
Inner Mongolian, China. All animals were negative to
BVDV and apparently healthy, presenting no signs of
depression, cough or other health disorders. The selected
animals were transported to an animal facility in Inner
Mongolian. All animal experiments were approved by the
Institutional Animal Care and Use Committee of Jilin
University.
Virus infection and temperature recording
Three days prior to challenge, all animals were transferred
to a bio-level 3 safety facility. Four calves were intranasally
inoculated with 6 ml of cell culture medium containing
106.8TCID50 per milliliter of the HN01 strain, and other
two calves were inoculated with the cell culture medium
to serve as the controls. All the culture medium were
demonstrated free of adventitious pathogens. The chal-
lenge procedure was performed by spraying 3 ml of virus
samples into each nostril, using an atomizer, and then the
calves were monitored for 8 days. The temperature was
taken two times at the same time every day by investiga-
tors who were unaware of the treatment codes in each
study. Three randomly chosen calves were euthanized at
8 dpi for histopathology analysis.
Clinical assessment
Calves were clinically observed daily from 1 to 8 days
post-challenge. Clinical signs including depression, cough,
asthma, and other respiratory disease were recorded and
scored using a scale of 0 – 3 (0 = absence; 1 =mild;
2 =moderate; 3 = severe).
Sample collection
White blood cell (WBC) counts were conducted from 2
days pre-challenge through 8 days post-challenge and white
blood cell (WBC) counts were conducted by a Vetscan
HM5 veterinary hematology system (Abaxis, USA). Deep
nasal swab specimens were collected at 1 day prior to chal-
lenge through 8 days post-challenge. After collection, swabs
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medium, consisting of DMEM (HyClone, USA) supple-
mented with 10% horse serum (Hyclone, USA), 150 μg/ml
gentamicin sulfate (Sigma, USA), 7.5 μg/ml fungizone and
streptomycin at 100 μg/ml. The samples were kept at 2-8°C
and quickly transferred to the laboratory. Upon arriving in
laboratory, all swab specimens were stored at -70°C or
below until they were cultured for virus isolation.Histopathologic study
On days 8 dpi, two calves in the infected group and one
in the control group were euthanized; tissue samples of
liver, spleen, lung, heart, kidney, intestine, mandibular
lymph node, and mesenteric lymph node were collected
and fixed in 10% buffered formalin for histopathologic
analysis in Inner Mongolia agricultural university.
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